Congress Responds: A Congressional Investigation of Mylan
Last week, I gave an interview with Fox Business in which we discuss the skyrocketing price of EpiPens, Mylan’s monopoly and their 90% market share in the epinephrine auto-injector space. In the days that followed, Mylan was first silent and then appeared “frustrated.” In response to an onslaught of negative press, the company is now offering…